Luise Maute

Suggest Changes
Learn More
BACKGROUND Pancreatic ductal adenocarcinoma (PDAC) is one of the most common malignant tumours and is still associated with a poor prognosis in advanced disease. To improve the standard therapy with(More)
To detail tolerance of temsirolimus in a routine practice setting within a compassionate use program for patients with renal cell carcinoma. We treated 32 patients with advanced renal cell carcinoma(More)